Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
2 result(s) for "Hadade, Rodrigo"
Sort by:
Memory complaints after COVID-19: a potential indicator of primary cognitive impairment or a correlate of psychiatric symptoms?
Cognitive impairment and symptoms of psychiatric disorders have been reported frequently as features of post-acute sequelae of SARS-CoV-2 infection. This study aims to investigate subjective memory complaints in COVID-19 survivors and determine if these are more strongly associated with objective cognitive impairment related to sequelae of SARS-CoV-2 infection or with symptoms of psychiatric conditions. A total of 608 COVID-19 survivors were evaluated in-person 6–11 months after hospitalization, with 377 patients assigned to a “no subjective memory complaint (SMC)” group and 231 patients assigned to an SMC group based on their Memory Complaint Scale scores. Follow-up evaluations included an objective cognitive battery and scale-based assessments of anxiety, depression, and post-traumatic stress symptoms. We found the perception of memory impairment in COVID-19 survivors to be more strongly associated to core symptoms of psychiatric conditions rather than to primary objective cognitive impairment. Univariate analysis indicated significant differences between the “no SMC” and SMC groups, both for the psychiatric symptom evaluations and for the cognitive evaluations (p < 0.05); however, the psychiatric symptoms all had large partial eta-squared values (ranging from 0.181 to 0.213), whereas the cognitive variables had small/medium partial eta-squared values (ranging from 0.002 to 0.024). Additionally, multiple regression analysis indicated that only female sex and depressive and post-traumatic stress symptoms were predictors of subjective memory complaints. These findings may help guide clinical evaluations for COVID-19 survivors presenting with memory complaints while also serving to expand our growing understanding of the relationship between COVID-19, subjective memory complaints, and the risk of cognitive decline.
Memory complaints after COVID‐19: a potential indicator of primary cognitive impairment or a correlate of psychiatric symptoms?
Cognitive impairment and symptoms of psychiatric disorders have been reported frequently as features of post‐acute sequelae of SARS‐CoV‐2 infection. This study aims to investigate subjective memory complaints in COVID‐19 survivors and determine if these are more strongly associated with objective cognitive impairment related to sequelae of SARS‐CoV‐2 infection or with symptoms of psychiatric conditions. A total of 608 COVID‐19 survivors were evaluated in‐person 6 to 11 months after hospitalization, with 377 patients assigned to a “no SMC” group and 231 patients assigned to an SMC group based on their Memory Complaint Scale scores. Follow‐up evaluations included an objective cognitive battery and scale‐based assessments of anxiety, depression, and post‐traumatic stress symptoms. We found the perception of memory impairment in COVID‐19 survivors to be more strongly associated to core symptoms of psychiatric conditions rather than to primary objective cognitive impairment. Univariate analysis indicated significant differences between the “no SMC” and SMC groups, both for the psychiatric symptom evaluations and for the cognitive evaluations (p<0.05); however, the psychiatric symptoms all had large eta‐squared values (ranging from 0.181 to 0.213), whereas the cognitive variables had small/medium eta‐squared values (ranging from 0.002 to 0.024). Additionally, multiple regression analysis indicated that only female sex and depressive and post‐traumatic stress symptoms were found to be predictors of subjective memory complaints. These findings may help guide clinical evaluations for COVID‐19 survivors presenting with memory complaints while also serving to expand our growing understanding of the relationship between COVID‐19, subjective memory complaints, and the risk of cognitive decline.